QuiVad

Home / Japan / Taiko Pharmaceutical Co.,ltd.

Taiko Pharmaceutical Co.,ltd.

Short position disclosed on November 2, 2026.

Follow

Evolution of the disclosed total

0%2%4%6%
Aug 22Sep 10Sep 29Oct 18
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.

Open positions

The funds disclosing a short position that is still open.
FundTwelve months% of capitalOver the yearSince
モルガン・スタンレーmufg証券株式会社0.70%newNovember 2, 2026
Nomura International plc0.48%newOctober 29, 2026

Follow by RSS

Get the moves on Taiko Pharmaceutical Co.,ltd. by mail, at most once a day.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

58 disclosures on record for this share.
DateFund% of capitalEnd of publication
August 13, 2026Arrowstreet Capital, Limited Partnership0.48%
August 12, 2026Goldman Sachs International1.69%
August 7, 2026Nomura International plc0.78%
August 7, 2026大和証券株式会社0.70%
August 5, 2026JPM Securities Japan Co Ltd.0.60%
August 4, 2026Goldman Sachs International1.77%
August 4, 2026Arrowstreet Capital, Limited Partnership0.59%
August 3, 2026Goldman Sachs International1.80%

Download 58 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in Japan

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Taiko Pharmaceutical Co.,ltd., source JPX, data as at November 2, 2026, https://www.quivad.com/action/taiko-pharmaceutical-co-ltd?page=2